A joint venture for the development of Apoptotic fusion proteins for the treatment of asthma and allergic diseases is in collaboration with a Israeli Biotech company based on research undertaken by University of Jerusalem.
Gujarat Venture Finance Limited has been an equity partner since 2008.
We are exploring further for co-development partnerships with Indian and foreign companies.
|
